Pathophysiology • Respiratory Pathophysiology

Obstructive vs. Restrictive Patterns

Distinguishing impaired airflow from reduced lung expansion through spirometric patterns and clinical reasoning.

A changing vital sign with DNA and microscope symbols for the study of disease processes.
Inside this lesson 10 sections 5 questions 7 figures

SECTION 1

Historical Context & Motivation

The ability to classify pulmonary disease into obstructive and restrictive patterns did not arise overnight; it was the product of centuries of evolving thought about the mechanics of breathing. Early physicians recognized that some patients wheezed and struggled to exhale while others simply could not take a deep breath, yet these observations remained anecdotal until objective measurement became possible. The development of spirometry transformed respiratory medicine by providing quantifiable data that could separate these two broad categories, guiding diagnosis, prognosis, and treatment decisions that clinicians rely on every day.

1846 • Hutchinson's Spirometer

John Hutchinson invented the spirometer and introduced the concept of vital capacity (VC), demonstrating that lung volume measurements correlated with mortality risk and laying the groundwork for objective pulmonary function testing.

1947 • Tiffeneau and the Timed Vital Capacity

Robert Tiffeneau introduced the concept of measuring the volume exhaled in the first second of a forced expiration (FEV₁), enabling clinicians to quantify airflow limitation for the first time.

1958 • FEV₁/FVC Ratio Standardized

The FEV₁/FVC ratio became the primary criterion for distinguishing obstructive from restrictive physiology, a classification that persists in modern pulmonology guidelines.

2005 • ATS/ERS Standardization

The American Thoracic Society and European Respiratory Society published comprehensive guidelines standardizing spirometric technique, interpretation algorithms, and severity grading for both obstructive and restrictive patterns.

The central question these historical advances addressed remains the same question facing every healthcare student today: when a patient presents with dyspnea, how do we determine whether the problem lies in getting air out of the lungs (obstruction) or in getting air into the lungs (restriction)? Answering this question is the foundation upon which virtually all respiratory diagnosis is built.

SECTION 2

Core Principles & Definitions

Pulmonary function testing divides respiratory disorders into two fundamental physiological patterns based on how airflow and lung volumes are affected. Understanding the distinction requires familiarity with several key spirometric parameters and the mechanical principles that underlie each pattern. The obstructive pattern is characterized by difficulty expelling air due to narrowed or collapsible airways, whereas the restrictive pattern reflects an inability to fully expand the lungs due to parenchymal, pleural, or chest wall pathology. Both patterns produce dyspnea, yet they arise from fundamentally different derangements in respiratory mechanics.

1

FEV₁ — Forced Expiratory Volume in 1 Second

The volume of air a patient can forcibly exhale in the first second of a maximal expiration. Reduced in both obstructive and restrictive disease, making it insufficient as a standalone discriminator.
2

FVC — Forced Vital Capacity

The total volume of air exhaled during a forced expiration from full inspiration to complete expiration. Reduced significantly in restrictive disease; may be normal or reduced in obstructive disease due to air trapping.
3

FEV₁/FVC Ratio — The Key Discriminator

The proportion of the vital capacity expelled in the first second. A ratio below 0.70 (or below the lower limit of normal) indicates obstruction; a normal or elevated ratio with reduced FVC suggests restriction.
4

TLC — Total Lung Capacity

The total volume of air in the lungs after maximal inhalation. Increased in obstructive disease (hyperinflation), decreased in restrictive disease. Requires body plethysmography or gas dilution for measurement.
5

RV — Residual Volume

The volume of air remaining in the lungs after maximal expiration. Characteristically elevated in obstructive disease due to air trapping, while reduced in restrictive disease.
✦

KEY TAKEAWAY

Think of the lungs as a balloon. In obstructive disease, the balloon fills normally but the opening is pinched — air gets trapped inside and cannot escape quickly. In restrictive disease, the balloon itself is stiff or small — it simply cannot fill to its normal capacity. The FEV₁/FVC ratio tells you whether the problem is the opening (obstruction) or the balloon (restriction).

SECTION 3

Visual Explanation — Flow-Volume & Volume-Time Curves

Volume-Time Curves: Normal vs. Obstructive vs. RestrictiveVolume (L)Time (seconds)012345012345NormalFEV₁ ≈ 3.9 LObstructiveFEV₁ ≈ 2.2 LRestrictiveFEV₁ ≈ 2.9 LPattern Signatures:Normal: steep rise, high plateauObstructive: slow rise, delayed plateauRestrictive: steep rise, low plateauDashed vertical = 1-second mark (FEV₁)
Volume-time curves illustrating three spirometric patterns. The normal curve (green) rises steeply and plateaus at a high FVC. The obstructive curve (pink) rises slowly with a concave pattern, reflecting prolonged expiration and air trapping. The restrictive curve (amber) rises steeply but plateaus at a reduced total volume, reflecting diminished lung capacity.

The volume-time curve is the most intuitive way to visualize the difference between obstructive and restrictive patterns. In a normal individual, forced expiration produces a steep, almost vertical initial rise as air rushes out of unobstructed airways, with the curve plateauing within approximately three seconds as the lungs approach residual volume. The obstructive pattern is immediately recognizable by its concave, slowly rising trajectory — the patient continues to exhale for six seconds or more but never achieves a true plateau because air is trapped behind narrowed airways. Notice that the FEV₁ is markedly reduced while the eventual FVC may be only mildly decreased, yielding a low FEV₁/FVC ratio. In contrast, the restrictive pattern preserves the steep initial slope because the airways themselves are patent; the curve simply plateaus prematurely at a reduced volume, reflecting the diminished total capacity of the lungs. Both FEV₁ and FVC fall proportionally, so the FEV₁/FVC ratio remains normal or even increases.

SECTION 4

Pathophysiological Mechanisms

Obstructive Mechanism: Airflow Limitation

Obstructive lung diseases share a common physiological endpoint: increased resistance to airflow, predominantly during expiration. The mechanisms driving this resistance vary by disease. In asthma, bronchospasm, mucosal edema, and mucus hypersecretion collectively narrow the airway lumen, increasing resistance according to Poiseuille's law. In chronic obstructive pulmonary disease (COPD), two overlapping processes contribute: chronic bronchitis produces airway wall thickening and mucus plugging, while emphysema destroys alveolar walls and the radial traction that normally holds small airways open during expiration. The loss of elastic recoil in emphysema is particularly important because it reduces the driving pressure for expiratory flow and promotes dynamic airway compression — as intrathoracic pressure rises during forced expiration, unsupported airways collapse, trapping air distal to the point of closure.

POISEUILLE'S LAW — AIRWAY RESISTANCE

R=8ηL/πr4R = 8ηL / πr⁴

Where R = resistance, η = viscosity of air, L = airway length, r = airway radius. Because resistance is inversely proportional to the fourth power of the radius, even a small reduction in airway caliber produces a dramatic increase in resistance. A 50% reduction in radius increases resistance 16-fold.

Restrictive Mechanism: Volume Limitation

Restrictive disorders reduce the total volume of air the lungs can accommodate. The underlying causes fall into two broad categories. Intrinsic (pulmonary) restriction arises from pathology within the lung parenchyma itself — conditions such as idiopathic pulmonary fibrosis, pneumoconioses, and sarcoidosis replace normal alveolar tissue with fibrotic scar tissue, increasing lung stiffness (decreased compliance). Extrinsic (extrapulmonary) restriction results from factors outside the lung parenchyma that limit thoracic expansion — neuromuscular diseases (e.g., myasthenia gravis, Guillain-Barré syndrome), chest wall deformities (e.g., severe kyphoscoliosis), obesity hypoventilation syndrome, and large pleural effusions. In both categories, the total lung capacity is reduced, which is the definitive hallmark of restriction.

COMPLIANCE — LUNG STIFFNESS

C=ΔV/ΔPC = ΔV / ΔP

Where C = compliance (L/cmH₂O), ΔV = change in volume, ΔP = change in transpulmonary pressure. In pulmonary fibrosis, compliance is markedly decreased — a greater pressure change is required to achieve the same volume change, producing a stiff lung that resists expansion.

SECTION 5

Disease Classification & Spirometric Patterns

Classification of Obstructive & Restrictive Lung DiseasesPulmonary Function TestingOBSTRUCTIVE (FEV₁/FVC < 0.70)RESTRICTIVE (TLC < 80% pred)Airway Diseases• Asthma• Chronic Bronchitis• Bronchiectasis• Cystic Fibrosis↑ Airway resistance± ReversibleParenchymal• Emphysema (panacinar) (centriacinar)↓ Elastic recoil↑ ComplianceNot reversibleIntrinsic (Pulmonary)• Pulmonary Fibrosis• Sarcoidosis• Pneumoconioses• ARDS↓ Compliance↑ Elastic recoil↓ DLCOExtrinsic (Extrapulm.)• Kyphoscoliosis• Obesity• Neuromuscular Dz• Pleural EffusionNormal DLCO↓ Chest wall complianceor ↓ muscle strengthKey Spirometric DifferencesObstructiveRestrictiveFEV₁/FVC < 0.70 | TLC ↑ | RV ↑FEV₁/FVC ≥ 0.70 | TLC ↓ | RV ↓
Classification tree showing the major categories of obstructive and restrictive lung diseases. Obstructive diseases are further divided into airway-predominant (asthma, bronchitis) and parenchymal-predominant (emphysema) subtypes. Restrictive diseases are divided into intrinsic (pulmonary fibrosis, sarcoidosis) and extrinsic (neuromuscular, chest wall) categories, each with distinct DLCO patterns.
ParameterObstructive PatternRestrictive Pattern
FEV₁↓↓ Markedly decreased↓ Decreased
FVCNormal or ↓ (air trapping)↓↓ Markedly decreased
FEV₁/FVC Ratio↓ < 0.70 (decreased)Normal or ↑ (≥ 0.70)
TLC↑ Increased (hyperinflation)↓↓ Decreased (hallmark)
RV↑ Increased (air trapping)↓ Decreased
RV/TLC Ratio↑ IncreasedNormal
DLCO↓ in emphysema; normal in asthma/bronchitis↓ in intrinsic; normal in extrinsic

Comparison of spirometric and lung volume parameters in obstructive versus restrictive patterns

SECTION 6

Worked Example — Interpreting a PFT Report

A 62-year-old male with a 40-pack-year smoking history presents with progressive exertional dyspnea. His pulmonary function test results are as follows: FEV₁ = 1.5 L (42% predicted), FVC = 3.8 L (82% predicted), FEV₁/FVC = 0.39, TLC = 8.2 L (128% predicted), RV = 4.4 L (195% predicted), DLCO = 48% predicted. Post-bronchodilator FEV₁ improves by 5% (80 mL). Interpret these findings.

PFT Interpretation: Step-by-Step Approach

  1. 1

    Step 1 — Assess the FEV₁/FVC Ratio

    The first step in any PFT interpretation is to examine the FEV₁/FVC ratio. This patient's ratio is 0.39, which is well below the threshold of 0.70. This immediately identifies an obstructive pattern. The disproportionate reduction of FEV₁ relative to FVC confirms that the primary problem is impaired expiratory airflow, not reduced lung volume.
    FEV₁/FVC = 0.39 → Obstructive pattern confirmed
  2. 2

    Step 2 — Grade the Severity

    Using ATS/ERS guidelines (or GOLD criteria for COPD), severity is graded based on the FEV₁ expressed as a percentage of the predicted value. This patient's FEV₁ is 42% predicted. According to GOLD staging: Stage I (mild) ≥ 80%, Stage II (moderate) 50–79%, Stage III (severe) 30–49%, Stage IV (very severe) < 30%. An FEV₁ of 42% predicted falls into GOLD Stage III — Severe Obstruction.
    FEV₁ = 42% predicted → Severe obstruction (GOLD III)
  3. 3

    Step 3 — Evaluate Lung Volumes

    The TLC is 128% predicted (elevated), and the RV is 195% predicted (markedly elevated). These findings are consistent with air trapping and hyperinflation, hallmarks of obstructive disease. The elevated TLC also rules out a concomitant restrictive process, since restriction would reduce TLC below 80% predicted.
    TLC ↑, RV ↑↑ → Air trapping; no restriction
  4. 4

    Step 4 — Assess DLCO and Bronchodilator Response

    The DLCO is 48% predicted, indicating significant impairment of gas exchange at the alveolar-capillary membrane. A reduced DLCO in the context of obstruction points toward emphysema rather than pure chronic bronchitis (which typically preserves DLCO). The post-bronchodilator response shows only a 5% improvement (80 mL), which does not meet the threshold for significant reversibility (≥ 12% AND ≥ 200 mL improvement in FEV₁). This pattern is consistent with COPD rather than asthma.
    ↓ DLCO + poor reversibility → COPD with emphysema component
  5. 5

    Step 5 — Synthesize the Clinical Picture

    Integrating the spirometric data with the clinical history: this patient has severe obstructive disease (GOLD III) with significant air trapping, hyperinflation, and reduced diffusing capacity consistent with an emphysema-predominant COPD phenotype. The 40-pack-year smoking history strongly supports this diagnosis. The irreversible obstruction distinguishes this from asthma. Management would include smoking cessation, long-acting bronchodilators, and potentially pulmonary rehabilitation.
    Final Interpretation: Severe obstructive pattern (GOLD III), emphysema-predominant COPD, with air trapping and reduced gas exchange.

SECTION 7

Clinical Features — Obstructive vs. Restrictive

Clinical FeatureObstructive DiseaseRestrictive Disease
Primary SymptomDyspnea on exertion; difficulty exhalingDyspnea on exertion; difficulty inhaling
Breathing PatternProlonged expiratory phase; pursed-lip breathingRapid, shallow breathing (↑ RR, ↓ Vт)
AuscultationWheezes, rhonchi, diminished breath soundsFine inspiratory crackles ("Velcro" crackles in fibrosis)
Chest ImagingHyperinflated lungs, flattened diaphragms, increased AP diameterReduced lung volumes, reticular opacities, honeycombing
ABG PatternHypoxemia ± hypercapnia; respiratory acidosis in severe casesHypoxemia with normal or low PaCO₂ (compensatory tachypnea)
Common CausesCOPD, asthma, cystic fibrosis, bronchiectasisIPF, sarcoidosis, obesity, neuromuscular disease, kyphoscoliosis

Side-by-side comparison of clinical features in obstructive versus restrictive lung disease

💡

CLINICAL PEARL

A common pitfall is assuming that a reduced FVC on spirometry alone confirms restriction. In obstructive disease, air trapping can reduce the FVC measured by spirometry even though TLC is actually increased. This is why a reduced TLC on plethysmography — not a reduced FVC — is required to confirm true restriction. If spirometry suggests restriction (normal FEV₁/FVC with low FVC), always order lung volumes before diagnosing a restrictive pattern, as up to 40% of such cases actually represent obstruction with air trapping.

SECTION 8

Mixed Patterns & Advanced Concepts

While the obstructive-restrictive dichotomy provides a powerful framework for organizing respiratory disease, many patients in clinical practice do not fit neatly into one category. A mixed obstructive-restrictive pattern is identified when both the FEV₁/FVC ratio is reduced (confirming obstruction) AND the TLC is reduced below 80% predicted (confirming coexistent restriction). This combination can occur, for example, in a COPD patient who also has pulmonary fibrosis, a patient with congestive heart failure superimposed on asthma, or an obese smoker with both airway disease and chest wall restriction. Recognizing mixed patterns is clinically essential because treatment must address both components simultaneously.

FeaturePure ObstructivePure RestrictiveMixed Pattern
FEV₁/FVC< 0.70≥ 0.70 (often > 0.80)< 0.70
TLCNormal or ↑< 80% predicted< 80% predicted
FVCNormal or mildly ↓↓↓↓↓
Clinical ExampleCOPD, asthmaIPF, kyphoscoliosisCOPD + obesity; COPD + fibrosis

Distinguishing pure obstructive, pure restrictive, and mixed obstructive-restrictive patterns

Advanced pulmonary function testing extends beyond standard spirometry and plethysmography. The diffusing capacity for carbon monoxide (DLCO) helps differentiate within categories: in obstructive disease, a reduced DLCO suggests emphysema (destroyed alveolar surface area), while a preserved DLCO points toward chronic bronchitis or asthma. In restrictive disease, a reduced DLCO indicates intrinsic parenchymal disease (fibrosis), while a normal DLCO suggests extrinsic restriction where the lung parenchyma itself is normal. As you progress into clinical rotations and advanced respiratory coursework, you will also encounter impulse oscillometry and cardiopulmonary exercise testing (CPET), which provide even more nuanced evaluation of respiratory mechanics and gas exchange during physiological stress.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A patient's spirometry shows a reduced FEV₁/FVC ratio of 0.58. Their FVC is 95% of predicted, and their TLC is 112% of predicted. Is this pattern obstructive, restrictive, or mixed? Explain why the TLC finding is important in classifying this pattern.
Show answer
This is a pure obstructive pattern. The FEV₁/FVC ratio of 0.58 is below the 0.70 threshold, confirming airflow obstruction. The preserved FVC (95% predicted) indicates that the total volume of air exhaled is normal; the problem is the rate at which it is expelled. The TLC of 112% predicted is above the lower limit of normal, ruling out any coexistent restrictive process and actually suggesting mild hyperinflation from air trapping. If the TLC had been below 80% predicted, a mixed pattern would be diagnosed despite the normal FVC.

Question 2: BASIC CALCULATION

A 45-year-old patient performs spirometry with the following results: FEV₁ = 2.1 L, FVC = 2.4 L. Calculate the FEV₁/FVC ratio. Is this obstructive or restrictive? If the predicted FVC for this patient is 4.2 L, what additional test would you order, and what result would confirm your suspected pattern?
Show answer
The FEV₁/FVC ratio = 2.1 ÷ 2.4 = 0.875 (87.5%). This ratio is normal (≥ 0.70), so obstruction is not the primary pattern. However, the FVC is only 57% of predicted (2.4 ÷ 4.2 = 0.57), which is significantly reduced. This combination — normal or elevated ratio with reduced FVC — suggests a restrictive pattern, but spirometry alone cannot confirm restriction. You should order lung volume measurement (body plethysmography or helium dilution). A TLC below 80% predicted would confirm true restriction. If TLC were normal or elevated, the low FVC might instead reflect poor effort, air trapping, or a nonspecific pattern.

Question 3: INTERMEDIATE

Two patients both present with an FEV₁ of 60% predicted. Patient A has an FEV₁/FVC ratio of 0.52 and a DLCO of 40% predicted. Patient B has an FEV₁/FVC ratio of 0.52 and a DLCO of 82% predicted. Both have a significant smoking history. What obstructive disease subtype does each likely represent, and what is the pathophysiological basis for the DLCO difference?
Show answer
Both patients have obstructive patterns (FEV₁/FVC < 0.70 with moderate severity at 60% predicted FEV₁). Patient A's markedly reduced DLCO (40%) suggests emphysema-predominant COPD. In emphysema, destruction of alveolar walls reduces the surface area available for gas exchange, directly decreasing the diffusing capacity for carbon monoxide. Patient B's preserved DLCO (82%) suggests chronic bronchitis-predominant COPD. In chronic bronchitis, the primary pathology involves the airways (mucus hypersecretion, airway wall thickening) rather than the alveolar parenchyma, so the alveolar-capillary membrane remains largely intact and DLCO is preserved. This distinction has treatment implications, as emphysema patients may benefit from earlier consideration of surgical interventions such as lung volume reduction surgery.

Question 4: APPLIED

A 35-year-old construction worker presents with progressive dyspnea over 2 years. His PFT results show: FEV₁ = 2.8 L (72% predicted), FVC = 3.1 L (68% predicted), FEV₁/FVC = 0.90, TLC = 3.6 L (62% predicted), DLCO = 45% predicted. Chest CT shows bilateral upper-lobe fibrotic changes and eggshell calcification of hilar lymph nodes. Classify the spirometric pattern, identify the most likely diagnosis, and explain why the DLCO finding is consistent with this diagnosis.
Show answer
This is a restrictive pattern. The FEV₁/FVC ratio of 0.90 is normal (no obstruction), while the TLC at 62% predicted confirms reduced lung volumes. Both FEV₁ and FVC are reduced proportionally. The clinical picture — a construction worker with progressive fibrosis and eggshell calcification of hilar lymph nodes — is classic for silicosis, a pneumoconiosis resulting from chronic inhalation of silica dust. The reduced DLCO (45%) is consistent with an intrinsic restrictive process because the fibrotic tissue replaces normal alveolar architecture, thickening the alveolar-capillary membrane and reducing the surface area available for gas diffusion. If this were an extrinsic cause (e.g., neuromuscular disease), the DLCO would typically be normal because the lung parenchyma itself is unaffected.

Question 5: CRITICAL THINKING

A patient's spirometry reveals: FEV₁ = 1.8 L (50% predicted), FVC = 2.5 L (60% predicted), FEV₁/FVC = 0.72. The clinician initially calls this "borderline normal" and does not order further testing. Critically evaluate this interpretation. Consider the limitations of using a fixed 0.70 cutoff, the concept of the lower limit of normal (LLN), and what additional information you would need to reach a definitive conclusion.
Show answer
This interpretation is problematic for several reasons. First, the fixed FEV₁/FVC cutoff of 0.70 has known limitations: in elderly patients, the normal FEV₁/FVC ratio naturally declines with age, leading to overdiagnosis of obstruction; in younger patients, the normal ratio is typically 0.80–0.85, meaning a ratio of 0.72 in a young adult may represent true obstruction missed by the fixed cutoff. The ATS/ERS guidelines recommend using the lower limit of normal (LLN), defined as the 5th percentile of a healthy reference population matched for age, sex, height, and ethnicity. If this patient's LLN for FEV₁/FVC is 0.75 (as it would be for a younger patient), then 0.72 falls below the LLN and confirms obstruction. Second, the FVC at 60% predicted is significantly reduced, and without lung volume measurement, we cannot determine whether this represents air trapping from obstruction or a concomitant restrictive process. TLC measurement is essential. Finally, a bronchodilator challenge and clinical correlation (symptoms, smoking history, imaging) would further refine the diagnosis. This case illustrates why algorithmic PFT interpretation must incorporate the LLN, complete lung volumes, and clinical context — relying solely on a single fixed ratio risks both missed diagnoses and inappropriate treatment.

SUMMARY

Lesson Summary

Summary

Pulmonary function testing classifies respiratory disease into two fundamental patterns. The obstructive pattern is defined by a reduced FEV₁/FVC ratio (< 0.70), reflecting impaired expiratory airflow caused by airway narrowing, mucus plugging, or loss of elastic recoil. Classic obstructive diseases include COPD, asthma, bronchiectasis, and cystic fibrosis. Key features include air trapping (elevated RV), hyperinflation (elevated TLC), and a concave, slowly rising volume-time curve. Severity is graded by FEV₁ percent predicted using GOLD or ATS/ERS criteria.

The restrictive pattern is defined by a reduced TLC (< 80% predicted) with a preserved or elevated FEV₁/FVC ratio, reflecting inability to fully expand the lungs. Causes are divided into intrinsic (pulmonary) — such as pulmonary fibrosis, which increases lung stiffness and reduces DLCO — and extrinsic (extrapulmonary) — such as neuromuscular disease or chest wall deformity, where DLCO remains normal. A mixed pattern exists when both a low FEV₁/FVC ratio and a low TLC are present. Always remember: spirometry suggests a pattern, but lung volume measurement confirms restriction, and clinical context — including history, imaging, DLCO, and bronchodilator response — is essential for definitive diagnosis.

Varsity Tutors • Pathophysiology • Obstructive vs. Restrictive Patterns